OncBioMune Overview
- Year Founded
-
2005

- Status
-
Private
- Employees
-
5

- Latest Deal Type
-
Reverse Merger
- Financing Rounds
-
1
- Investments
-
1
OncBioMune General Information
Description
Developer of biotechnology products for cancer treatment. The company engages in marketing and distribution of hospital specialty pharmaceutical prescription products.
Contact Information
Website
www.oncbiomune.comCorporate Office
- 17050 Medical Center Drive
- Baton Rouge, LA 70816
- United States
Corporate Office
- 17050 Medical Center Drive
- Baton Rouge, LA 70816
- United States
OncBioMune Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
OncBioMune Comparisons
Industry
Financing
Details
OncBioMune Competitors (38)
One of OncBioMune’s 38 competitors is Novartis, a Corporation company based in Basel, Switzerland.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Novartis | Corporation | Basel, Switzerland | ||||
Liquidia Technologies | Formerly VC-backed | Morrisville, NC | ||||
Abbott India | Corporation | Mumbai, India | ||||
Northwest Biotherapeutics | Corporate Backed or Acquired | Bethesda, MD | ||||
Merck & Co. | Corporation | Rahway, NJ |
OncBioMune Signals
OncBioMune Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
OncBioMune Acquisitions (1)
OncBioMune’s most recent deal was a Merger/Acquisition with Vitel Laboratorios. The deal was made on 10-Mar-2017.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Vitel Laboratorios | 10-Mar-2017 | Merger/Acquisition | Biotechnology |
OncBioMune FAQs
-
When was OncBioMune founded?
OncBioMune was founded in 2005.
-
Where is OncBioMune headquartered?
OncBioMune is headquartered in Baton Rouge, LA.
-
What is the size of OncBioMune?
OncBioMune has 5 total employees.
-
What industry is OncBioMune in?
OncBioMune’s primary industry is Drug Discovery.
-
Is OncBioMune a private or public company?
OncBioMune is a Private company.
-
What is OncBioMune’s current revenue?
The current revenue for OncBioMune is
. -
Who are OncBioMune’s investors?
Quint Media, Inc. has invested in OncBioMune.
-
Who are OncBioMune’s competitors?
Novartis, Liquidia Technologies, Abbott India, Northwest Biotherapeutics, and Merck & Co. are some of the 38 competitors of OncBioMune.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »